BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.
ONC Company Calendar
FEB. 26, 2026
Last Earnings
MAR. 7, 2026
Today
DEC. 31, 2026
Fiscal Year End
Recent BeOne Medicines News
Wed. March 4, 2026 10:41 AM EST | theglobeandmail.com
